PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Nov-2023 OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights Businesswire
09-Nov-2023 Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023 Businesswire
09-Nov-2023 Autobahn Therapeutics to Present at the Stifel 2023 Healthcare Conference Businesswire
09-Nov-2023 Odyssey Therapeutics to Present Data for Three Immunology Programs at American College of Rheumatology Convergence 2023 Businesswire
09-Nov-2023 Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China Businesswire
09-Nov-2023 Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates Businesswire
09-Nov-2023 Neonatal Seizures Drugs Market Set to Witness Unprecedented Growth of USD 290.73 Million by 2029 The Wire Times
09-Nov-2023 Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update Businesswire
09-Nov-2023 Antibe Reports PK Results of First Clinical Study of Otenaproxesul’s New Formulation Businesswire
09-Nov-2023 GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference Businesswire
09-Nov-2023 Vascular Embolization Market Updates: Predicted to Hit USD 7.8 Billion By 2031, at 7.7% CAGR, Report The Wire Times
09-Nov-2023 North America Dominates Cancer Stem Cell Market with Over 40% Share in 2023 The Wire Times
09-Nov-2023 Upstream Bioprocessing Market to Grasp Outstanding Growth of USD 14256.78 Million By 2029 The Wire Times
09-Nov-2023 AI image integrity tool now detects western band splicing Proofig AI
09-Nov-2023 OTC Artificial Tears Market Expected to Reach $6.4 Billion by 2028 | Current Trends and Industry Analysis The Wire Times
09-Nov-2023 Amino acid Metabolism Disorders Treatment Market Expected to Reach $961.8 Million by 2031 The Wire Times
09-Nov-2023 Global Urokinase Market (2023-2028) by Type, Dose Strength, Indication, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis - ResearchAndMarkets.com Businesswire
09-Nov-2023 Stevanato Group to Present at the Jefferies London Healthcare Conference Businesswire
09-Nov-2023 NICE recommends Lamzede®▼ (velmanase alfa) as first ever enzyme replacement therapy for initiation in children with alpha-mannosidosis in England and Wales in final evaluation document Chiesi
09-Nov-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire